Cyproheptadine Hydrochloride Tablet
Product Images NDC 76385-130

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyproheptadine Hydrochloride (NDC 76385-130). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unichem Pharmaceuticals (usa), Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cyproheptadine HCl Tablets 4 mg 100s Label (Container)

Label for Cyproheptadine Hydrochloride Tablets USP 4 mg, showing it as 100 oral tablets. Manufactured by Beximco Pharmaceuticals Ltd. and distributed by Bayshore Pharmaceuticals LLC. The label includes dosage instructions, storage conditions, barcode, and the Bayshore logo.*

FDA Label Image

Chemical Structure (Structure)

Chemical structure of Cyproheptadine Hydrochloride, showing its molecular arrangement with a tricyclic ring system and attached piperidine and methyl groups, along with the hydrochloride salt component marked as HCl.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.